News

Participation in the EU call INFRASTRUCTURE 2012.1.1.5

EATRIS wants to forward the process of integration and to accelerate the building of European translational research infrastructure

A leap forward in the effectiveness of biomedical research - for better patient outcomes

EATRIS marks official start to developing Europe’s translational research of the future
 
 
 
News

< Back to News overview
 

Participation in the EU call INFRASTRUCTURE 2012.1.1.5

EATRIS wants to forward the process of integration and to accelerate the building of European translational research infrastructure

The EATRIS I3 INFRA project proposal implements functioning international consortia of European translational research infrastructures, providing in-depth translational research services to external users. In 5 product groups (Vaccines, Imaging and Tracers, Biomarkers, ATMP's and Small Molecules), academic centres of excellence from 9 countries work together to create harmonised, European-wide access to existing infrastructure, covering a wide range of disease areas.

These platforms will cover most of the needs identified as bottlenecks for Translational Medicine for Academia and SME's in Europe.The project includes strong networking facilities, addressing key stakeholders such as academia, industry and patient groups. Outreach serves the purposes of encouraging debate and innovation, dissemination and best practice.

By enhancing scientific capacity, integrating the horizontal functions in the research services offering, organizing translational access and create long term financial sustainability, the I3 project allows EATRIS to make a flying start and to become a key player in translational research in the world in 4 years.

Due to a technical problem with the proposal software the submission did not correctly display the person-months per work package.  The correct version of the proposal, with person-months displayed, is available here.